Anwil, Switzerland

Eugen Eichenberger

This inventor holds 2 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugen Eichenberger. Retrieved from https://idiyas.com/inventor/eugen-eichenberger-kb2wr56r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Eugen Eichenberger

Introduction

Eugen Eichenberger is a notable inventor based in Anwil, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 2 patents to his name, Eichenberger's work has implications in various applications.

Latest Patents

Eichenberger's latest patents focus on intermediates for pyrazolyl acetic acid derivatives. The first patent discloses a novel process for the preparation of a compound of formula II, wherein R₁ is a C₁-5 alkyl. The second patent also addresses intermediates for pyrazolyl acetic acid derivatives, detailing a process involving the reaction of a 4-hydroxypyrazole of formula III with a benzylhalide of formula IV. These innovations highlight his expertise in organic synthesis and compound development.

Career Highlights

Eugen Eichenberger is currently associated with Sandoz GmbH, a leading global healthcare company. His role at Sandoz allows him to contribute to the advancement of pharmaceutical sciences. His work is characterized by a commitment to innovation and excellence in research.

Collaborations

Eichenberger has collaborated with Erwin Waldvogel, a fellow researcher, to further enhance the scope of their work in the field. Their partnership exemplifies the importance of teamwork in driving scientific advancements.

Conclusion

Eugen Eichenberger's contributions to the field of chemistry through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for future innovations in pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…